Download Sample
Add to CartGlobal Bioprocess Technology Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product;
Instrument and Consumables, and Accessories.By Instrument;
Bioprocess Analyzers, Osmometer, Blood Gas Analyzers, Cell Counter Systems, Bioreactors, Incubators, and Others.By Consumables and Accessories;
Culture Media, Reagents, and Others.By Application;
Recombinant Proteins, Monoclonal Antibodies, Antibiotics, and Biosimilars.By Technology;
Biopharmaceutical Companies, Contract Manufacturing Organization, Academic Research Institutes, Food and Feed industry, Contract Research Organizations, and Others.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global Bioprocess Technology Market (USD Million), 2021 - 2031
In the year 2024, the Global Bioprocess Technology Market was valued at USD 12,102.04 million. The size of this market is expected to increase to USD 16,915.59 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.9%.
The global bioprocess technology market stands at the forefront of innovation, revolutionizing industries ranging from pharmaceuticals to agriculture. With a focus on harnessing biological systems to produce valuable products, bioprocess technology encompasses a diverse array of techniques and methodologies. This market is driven by a confluence of factors, including increasing demand for biopharmaceuticals, advancements in biotechnology, and growing environmental concerns pushing for sustainable production practices. As a result, the bioprocess technology market is experiencing rapid expansion, poised to reshape the landscape of numerous sectors worldwide.
The global bioprocess technology market is the escalating demand for biopharmaceuticals. Biopharmaceuticals, derived from biological sources such as living organisms or their components, offer targeted therapies with high efficacy and fewer side effects compared to traditional pharmaceuticals. Consequently, pharmaceutical companies are increasingly investing in bioprocess technology to streamline the production of biologics such as monoclonal antibodies, vaccines, and gene therapies. This heightened demand for biopharmaceuticals is fueling the adoption of advanced bioprocessing techniques, driving innovation and expansion within the market.
The evolution of bioprocess technology is driven by continuous advancements in biotechnology and related fields. Breakthroughs in genetic engineering, cell culture techniques, and process automation are enhancing the efficiency, scalability, and cost-effectiveness of bioproduction processes. Furthermore, the integration of artificial intelligence and data analytics is optimizing bioprocess development and monitoring, enabling real-time adjustments for improved productivity and product quality. As these technological innovations continue to mature, the global bioprocess technology market is poised for sustained growth, offering promising solutions to meet the demands of a rapidly evolving global economy.
Global Bioprocess Technology Market Recent Developments
-
In June 2020, New GSv9 TM Media and Feeds was launched by Lonza. The product maximized yield and batch-to-batch consistency thus supporting and augmenting recombinant protein production. GSv9 is a chemically defined media and feeds platform which is developed to enhance the performance of the GS Gene Expression System.
-
In March 2020, Danaher Corporation completed its acquisition of the Biopharma Business from GE Company’s Life Sciences division. The business was renamed Cytiva, as a part of the Danaher Group and continues to act as a standalone company with the Life Sciences division of Danaher, thus aiding the group in expanding its portfolio in bioprocessing and technology.
Segment Analysis
The global bioprocess technology market is segmented by product into instruments and consumables, along with accessories, reflecting the comprehensive range of tools and materials required for bioprocessing operations. Instruments encompass a diverse array of equipment crucial for biomanufacturing, including bioprocess analyzers, osmometers, blood gas analyzers, cell counter systems, bioreactors, incubators, and others. These instruments enable precise monitoring, analysis, and control of bioproduction processes, ensuring optimal conditions for cell growth, product synthesis, and downstream purification.
The market comprises consumables and accessories essential for bioprocessing workflows. Consumables such as culture media and reagents provide the necessary nutrients, growth factors, and buffers required for cell culture, fermentation, and downstream processing. Accessories complement these consumables and instruments, including bioreactor components, filtration systems, tubing, and connectors. These consumables and accessories play a crucial role in facilitating efficient and reproducible bioproduction processes across various industries, including pharmaceuticals, biotechnology, and food and feed.
The application segmentation of the global bioprocess technology market highlights the diverse range of bioproducts manufactured using bioprocessing techniques. Key applications include the production of recombinant proteins, monoclonal antibodies, antibiotics, and biosimilars. Bioprocess technology enables the scalable and cost-effective manufacturing of these biologics, which find applications in therapeutics, diagnostics, and research. The market serves a wide range of end users, including biopharmaceutical companies, contract manufacturing organizations, academic research institutes, food and feed industries, contract research organizations, and others, reflecting the broad impact of bioprocessing across various sectors and its critical role in advancing healthcare, biotechnology, and industrial biomanufacturing.
Global Bioprocess Technology Segment Analysis
In this report, the Global Bioprocess Technology Market has been segmented by Product, Instrument, Consumables and Accessories, Application, Technology and Geography.
Global Bioprocess Technology Market, Segmentation by Product
The Global Bioprocess Technology Market has been segmented by Product into Instrument and Consumables and Accessories.
Instruments constitute a wide range of equipment crucial for biomanufacturing operations. These include bioprocess analyzers, osmometers, blood gas analyzers, cell counter systems, bioreactors, incubators, and other specialized devices. These instruments serve various purposes, from monitoring cell cultures to optimizing fermentation conditions, ensuring the efficient production of biologically derived products.
Complementing instruments, consumables play an equally essential role in bioprocessing workflows. These consumables encompass a broad spectrum of materials vital for cell culture, fermentation, and downstream processing. Culture media, growth factors, buffers, and reagents are among the consumables essential for nurturing cells, facilitating biochemical reactions, and purifying bio-based products. In addition to consumables, accessories such as bioreactor components, filtration systems, and tubing contribute to the seamless operation of bioprocessing facilities, enhancing efficiency and reproducibility.
The segmentation of the global bioprocess technology market into products reflects the holistic approach required in biomanufacturing. Instruments, consumables, and accessories collectively form the backbone of bioprocessing operations, enabling the production of diverse biologics and bio-based products. With continuous innovation and advancements in technology, these product segments continue to evolve, driving efficiency, scalability, and sustainability in bioprocessing industries worldwide. As such, they play a pivotal role in shaping the future of healthcare, biotechnology, and industrial biomanufacturing.
Global Bioprocess Technology Market, Segmentation by Instrument
The Global Bioprocess Technology Market has been segmented by Instrument into Bioprocess Analyzers, Osmometer, Blood Gas Analyzers, Cell Counter Systems, Bioreactors, Incubators, and Others.
In the dynamic realm of the global bioprocess technology market, instruments are segmented into various categories to address the specific needs and challenges encountered in bioprocessing operations. Bioprocess analyzers stand as indispensable tools for real-time monitoring and analysis of critical parameters such as pH, dissolved oxygen, and cell viability, ensuring optimal conditions for cell growth and product synthesis. Osmometers play a vital role in measuring osmotic pressure, aiding in the formulation of culture media and optimization of cell culture conditions. Blood gas analyzers enable precise measurement of gas concentrations, facilitating the control of gas exchange in bioreactors and ensuring proper oxygenation of cell cultures.
Cell counter systems offer efficient and accurate quantification of cell density and viability, enabling researchers and bioprocess engineers to assess cell growth kinetics and optimize culture conditions. Bioreactors represent the heart of bioprocessing facilities, providing controlled environments for cell culture and fermentation. These vessels come in various designs and configurations, including stirred-tank, airlift, and perfusion bioreactors, catering to diverse applications and scalability requirements. Incubators maintain stable temperature, humidity, and CO2 levels, creating ideal conditions for cell culture and promoting cell proliferation and product formation. Other instruments encompass a range of specialized devices and equipment, such as centrifuges, chromatography systems, and spectrophotometers, which play crucial roles in downstream processing and product purification.
The segmentation of instruments in the global bioprocess technology market reflects the multifaceted nature of bioprocessing operations and the diverse requirements across different stages of production. Each instrument category serves a specific function, contributing to the efficiency, reproducibility, and scalability of biomanufacturing processes. With advancements in technology and continuous innovation, these instruments continue to evolve, driving improvements in productivity, product quality, and regulatory compliance within the bioprocessing industry. As such, they play a pivotal role in advancing biotechnology, healthcare, and industrial biomanufacturing on a global scale.
Global Bioprocess Technology Market, Segmentation by Consumables and Accessories
The Global Bioprocess Technology Market has been segmented by Consumables and Accessories into Culture Media, Reagents, and Others.
In the realm of the global bioprocess technology market, consumables and accessories play a pivotal role in supporting the seamless execution of bioprocessing workflows. Culture media stands as a fundamental consumable, providing the essential nutrients, growth factors, and supplements necessary for nurturing cells in culture. Tailored formulations of culture media support the growth of specific cell types, optimizing productivity and ensuring the desired characteristics of the final product. Reagents constitute another critical category of consumables, encompassing biochemicals, buffers, and enzymes essential for various bioprocessing steps, from cell lysis and protein purification to assay development and analysis. These reagents enable precise control and manipulation of biological systems, facilitating the production of biologics with consistent quality and purity.
Beyond culture media and reagents, the segment of consumables and accessories includes a diverse array of materials and tools essential for bioprocessing operations. This encompasses filtration systems, chromatography columns, tubing, connectors, and other components necessary for downstream processing and product purification. Filtration systems play a crucial role in separating cells, debris, and particulates from culture supernatants, enabling clarification and concentration of bio-based products. Chromatography columns facilitate the purification of proteins and other biomolecules through affinity, ion exchange, size exclusion, or other chromatographic techniques, ensuring the removal of impurities and achieving high product yields and purity levels.
The segmentation of consumables and accessories in the global bioprocess technology market reflects the comprehensive approach required to support biomanufacturing processes effectively. Each category of consumables and accessories fulfills specific functions, contributing to the efficiency, reproducibility, and quality of bioprocessing operations. With advancements in materials science, manufacturing techniques, and process optimization, these consumables and accessories continue to evolve, enabling innovations in bioproduction and expanding the capabilities of biopharmaceutical companies, contract manufacturing organizations, and research institutions worldwide. As such, they constitute integral components of the bioprocess technology ecosystem, driving progress and advancements in biotechnology, healthcare, and industrial biomanufacturing.
Global Bioprocess Technology Market, Segmentation by Application
The Global Bioprocess Technology Market has been segmented by Application into Recombinant Proteins, Monoclonal Antibodies, Antibiotics, and Biosimilars.
In the dynamic landscape of the global bioprocess technology market, applications serve as focal points for the utilization of bioprocessing techniques in diverse industries. Recombinant proteins represent a significant application area, encompassing a wide range of therapeutic proteins, enzymes, hormones, and growth factors produced using recombinant DNA technology. Bioprocess technology plays a crucial role in the efficient production of recombinant proteins by providing scalable and controlled environments for the expression, purification, and characterization of these biotherapeutics. With increasing demand for protein-based therapeutics to address various medical conditions, the bioprocess technology market continues to witness significant growth in this application segment, driving innovation and advancements in biomanufacturing methodologies.
Monoclonal antibodies (mAbs) stand as another prominent application of bioprocess technology, revolutionizing the landscape of healthcare by offering targeted therapies for cancer, autoimmune diseases, and infectious diseases. Bioprocessing techniques enable the large-scale production of monoclonal antibodies through mammalian cell culture or microbial fermentation, ensuring high yields, purity, and efficacy of these biotherapeutics. The development of novel expression systems, purification strategies, and analytical methods further enhances the efficiency and cost-effectiveness of mAb production, fueling the expansion of the bioprocess technology market in this application domain.
Antibiotics, although traditional in the realm of pharmaceuticals, continue to be a crucial application area for bioprocess technology. Bioprocessing techniques facilitate the optimization and scale-up of fermentation processes for the production of antibiotics by microbial organisms such as bacteria and fungi. Through fermentation optimization, strain improvement, and downstream processing, bioprocess technology enables the cost-effective production of antibiotics with enhanced potency, stability, and purity. Moreover, the emergence of biosimilars, which are biologic products highly similar to existing approved biologics, presents new opportunities for bioprocess technology in the development and manufacturing of generic versions of biologic drugs, further diversifying the application landscape of the global bioprocess technology market.
Global Bioprocess Technology Market, Segmentation by Technology
The Global Bioprocess Technology Market has been segmented by Technology into Biopharmaceutical Companies, Contract Manufacturing Organization, Academic Research Institutes, Food and Feed industry, Contract Research Organizations, and Others.
In the expansive realm of the global bioprocess technology market, technology segments delineate the diverse stakeholders and industries leveraging bioprocessing techniques for various applications. Biopharmaceutical companies represent a significant segment, driving the demand for bioprocess technology to produce innovative biologic drugs, vaccines, and other therapeutic agents. These companies rely on advanced bioprocessing methods to optimize production processes, ensure product quality and consistency, and meet regulatory requirements. With the increasing adoption of biologics in healthcare, biopharmaceutical companies continue to fuel the growth of the bioprocess technology market, driving innovations and advancements in biomanufacturing.
Contract manufacturing organizations (CMOs) serve as essential partners for biopharmaceutical companies, offering expertise and infrastructure for the outsourced production of biologics. CMOs play a pivotal role in the bioprocess technology market by providing flexible manufacturing solutions, scalability, and cost-effective production options for biopharmaceuticals. These organizations utilize state-of-the-art bioprocessing facilities and technologies to meet the diverse needs of clients, ranging from small-scale clinical batches to large-scale commercial production. As the outsourcing trend in the biopharmaceutical industry continues to grow, CMOs emerge as key contributors to the expansion and evolution of the global bioprocess technology market.
Academic research institutes constitute another important segment within the global bioprocess technology market, driving innovation and knowledge generation in biotechnology and life sciences. These institutions contribute to the development of novel bioprocessing techniques, bioreactor designs, and analytical methods through fundamental research and applied studies. Academic researchers collaborate with industry partners and governmental agencies to address challenges in biomanufacturing, sustainability, and biopharmaceutical development. Their contributions to the advancement of bioprocess technology not only enrich scientific understanding but also catalyze technological innovations that benefit various industries, driving the growth and competitiveness of the global bioprocess technology market.
Global Bioprocess Technology Market, Segmentation by Geography
In this report, the Global Bioprocess Technology Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Bioprocess Technology Market Share (%), by Geographical Region, 2024
The global bioprocess technology market exhibits geographical segmentation, reflecting the diverse regional landscapes in terms of technological advancements, regulatory frameworks, and market dynamics. North America stands as a significant hub for bioprocess technology innovation, driven by the presence of leading biopharmaceutical companies, research institutions, and academic centers. With robust investments in research and development, coupled with favorable regulatory policies and infrastructure, North America leads the way in pioneering bioprocessing techniques and applications, particularly in areas such as recombinant proteins, monoclonal antibodies, and cell therapies.
Europe emerges as another prominent region in the global bioprocess technology market, characterized by a strong pharmaceutical industry, advanced healthcare infrastructure, and a supportive regulatory environment. European countries such as Germany, Switzerland, and the United Kingdom host renowned biotech clusters and bioprocessing facilities, fostering collaboration between industry, academia, and government entities. The region's focus on sustainability and green technologies further drives innovation in bioprocess technology, with initiatives aimed at reducing environmental impact and improving process efficiency.
The Asia Pacific region showcases rapid growth and expansion in the bioprocess technology market, fueled by the increasing demand for biopharmaceuticals, biosimilars, and industrial enzymes. Countries such as China, India, South Korea, and Japan are at the forefront of bioprocess technology adoption, supported by investments in biotechnology research, manufacturing infrastructure, and skilled workforce development. The presence of contract manufacturing organizations (CMOs) and contract research organizations (CROs) further accelerates the development and commercialization of biologic drugs and bio-based products in the region. Additionally, emerging economies in Southeast Asia offer untapped potential for market expansion, driven by government initiatives to promote biotechnology innovation and attract foreign investments.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Bioprocess Technology Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers:
- Growing Biotechnology Industry
- Growing Investments in Research and Development
- Increasing Focus on Sustainable Biomanufacturing
-
Increasing Demand for Biopharmaceuticals - The increasing prevalence of chronic diseases and the aging population globally have catalyzed a surge in demand for biopharmaceuticals, comprising monoclonal antibodies, recombinant proteins, vaccines, and cell therapies. Chronic conditions such as cancer, autoimmune disorders, diabetes, and cardiovascular diseases require targeted and personalized treatments, driving the development and adoption of biologic therapies. Monoclonal antibodies, for instance, have revolutionized cancer treatment by specifically targeting cancer cells while minimizing damage to healthy tissues. Similarly, recombinant proteins offer therapeutic solutions for various medical conditions, ranging from hormonal imbalances to enzyme deficiencies. Bioprocess technology plays a pivotal role in meeting this escalating demand by enabling the scalable production of these complex biologics with consistent quality and efficacy.
Bioprocess technology serves as the backbone of biopharmaceutical manufacturing, facilitating the efficient and cost-effective production of biologics at commercial scales. Advanced bioreactor designs, cell culture techniques, and downstream processing methods optimize the production process, enhancing yield, purity, and productivity. Additionally, process analytical technologies (PAT) and quality control systems ensure compliance with regulatory standards and product specifications. The scalability of bioprocess technology allows for the production of biopharmaceuticals in large quantities to meet the global healthcare demand, driving market growth and innovation in biomanufacturing.
The convergence of bioprocess technology with biopharmaceutical development addresses the unmet medical needs of patients worldwide while driving market expansion and technological advancement. As biopharmaceutical pipelines continue to expand with the development of novel therapies and biosimilars, bioprocess technology evolves to meet the evolving demands of the industry. Furthermore, collaborations between industry stakeholders, academia, and regulatory agencies facilitate knowledge exchange, research funding, and regulatory support, fostering a conducive environment for innovation and market growth. Overall, bioprocess technology plays a pivotal role in addressing healthcare challenges, improving patient outcomes, and driving the growth of the global biopharmaceutical market.
Restraints:
- Intellectual Property and Technology Transfer Issues
-
High Initial Capital Investment - The adoption of bioprocess technology in industries such as biopharmaceuticals, food and beverages, and bio-based manufacturing often requires substantial upfront investment in infrastructure, equipment, and skilled personnel. Bioreactors, purification systems, and analytical instruments are among the expensive equipment necessary for bioprocessing operations. Setting up bioprocessing facilities entails significant capital expenditure, including the construction of cleanrooms, installation of utilities, and procurement of specialized equipment. Moreover, recruiting and training personnel with expertise in bioprocess engineering, microbiology, and biotechnology adds to the initial investment costs. The high capital requirement acts as a deterrent for small and medium-sized enterprises (SMEs) or emerging biotech firms with limited financial resources, constraining their ability to adopt bioprocess technology and compete in the market.
Infrastructure and equipment costs, implementing bioprocess technology necessitates stringent quality control measures and compliance with regulatory standards. Biopharmaceutical manufacturing, in particular, is subject to rigorous regulatory oversight to ensure product safety, efficacy, and quality. Compliance with Good Manufacturing Practices (GMP), validation requirements, and documentation standards adds complexity and cost to bioprocessing operations. Moreover, navigating the regulatory landscape across different regions and countries further increases the compliance burden and regulatory-related expenses. For SMEs and emerging biotech firms, the need to invest in quality assurance and regulatory affairs expertise represents a significant barrier to adopting bioprocess technology, limiting their market access and growth prospects.
The high entry barrier posed by the substantial upfront investment and regulatory compliance requirements inhibits the widespread adoption of bioprocess technology among SMEs and emerging biotech firms. These organizations often face challenges in securing funding, accessing specialized expertise, and managing regulatory complexities, hindering their ability to leverage bioprocess technology for product development and commercialization. As a result, efforts to lower the cost of entry through financing mechanisms, technology-sharing initiatives, and regulatory support are essential to foster inclusivity and promote innovation in the global bioprocess technology market.
Opportunities:
- Focus on Sustainable Biomanufacturing
- Expansion of Biopharmaceutical Pipeline
-
Adoption of Single-Use Bioprocessing Technologies - The rise of single-use bioprocessing technologies marks a significant shift in the bioprocess technology market landscape, driven by their inherent advantages in flexibility, cost-effectiveness, and risk mitigation. Disposable bioreactors, filtration systems, and tubing assemblies offer biopharmaceutical companies greater flexibility in manufacturing processes, allowing for quicker turnaround times and easier adaptation to changing production needs. With single-use technologies, companies can streamline process development, scale-up, and manufacturing operations without the need for extensive cleaning and validation procedures associated with traditional stainless steel equipment.
Opportunities for innovation and expansion abound for bioprocess technology vendors in the single-use bioprocessing space. As demand grows for disposable bioreactors, filtration systems, and other single-use solutions, vendors have the opportunity to develop and introduce new products that address specific needs and challenges faced by biopharmaceutical manufacturers. Advancements in materials science, engineering, and automation are driving innovation in single-use technologies, enabling vendors to offer solutions with enhanced performance, reliability, and scalability. Moreover, strategic partnerships and collaborations with biopharmaceutical companies can facilitate the co-development of customized single-use solutions tailored to specific manufacturing requirements.
The adoption of single-use bioprocessing technologies presents a compelling value proposition for biopharmaceutical companies, offering benefits such as reduced capital investment, minimized risk of cross-contamination, and enhanced manufacturing flexibility. By eliminating the need for costly cleaning, sterilization, and validation processes associated with traditional stainless steel equipment, single-use technologies enable companies to lower operational costs and accelerate time-to-market for biologic drugs. The scalability and modular design of single-use systems allow companies to easily adjust production capacities in response to market demand fluctuations, optimizing resource utilization and enhancing overall manufacturing efficiency. As a result, the widespread adoption of single-use bioprocessing technologies is driving market growth and adoption, reshaping the bioprocess technology landscape towards more efficient and flexible manufacturing solutions.
Competitive Landscape Analysis
Key players in Global Bioprocess Technology Market include;
- Advanced Instruments, Inc.
- Nova Biomedical
- Thermo Fisher Inc.
- Sartorius AG
- Roche
- General Electric
- Danaher
- Lonza
- Siemens Healthneers
- Azenta US, Inc.
- Biomatrica, Inc.
- BioLife Solutions
- MVE Biological Solutions
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Instrument
- Market Snapshot, By Consumables and Accessories
- Market Snapshot, By Application
- Market Snapshot, By Technology
- Market Snapshot, By Region
- Global Bioprocess Technology Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Growing Biotechnology Industry
- Growing Investments in Research and Development
- Increasing Focus on Sustainable Biomanufacturing
- Increasing Demand for Biopharmaceuticals
- Restraints
- Intellectual Property and Technology Transfer Issues
- High Initial Capital Investment
- Opportunities
- Focus on Sustainable Biomanufacturing
- Expansion of Biopharmaceutical Pipeline
- Adoption of Single-Use Bioprocessing Technologies
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Bioprocess Technology Market, By Product, 2021 - 2031 (USD Million)
- Instrument
- Consumables and Accessories
- Global Bioprocess Technology Market, By Instrument, 2021 - 2031 (USD Million)
- Bioprocess Analyzers
- Osmometer
- Blood Gas Analyzers
- Cell Counter Systems
- Bioreactors
- Incubators
- Others
- Global Bioprocess Technology Market, By Consumables and Accessories, 2021 - 2031 (USD Million)
- Culture Media
- Reagents
- Others
- Global Bioprocess Technology Market, By Application, 2021 - 2031 (USD Million)
- Recombinant Proteins
- Monoclonal Antibodies
- Antibiotics
- Biosimilars
- Global Bioprocess Technology Market, By Technology, 2021 - 2031 (USD Million)
- Biopharmaceutical Companies
- Contract Manufacturing Organization
- Academic Research Institutes
- Food and Feed industry
- Contract Research Organizations
- Others
- Global Bioprocess Technology Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Bioprocess Technology Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Advanced Instruments, Inc.
- Nova Biomedical
- Thermo Fisher Inc.
- Sartorius AG
- Roche
- General Electric
- Danaher
- Lonza
- Siemens Healthneers
- Azenta US, Inc.
- Biomatrica, Inc.
- BioLife Solutions
- MVE Biological Solutions
- Company Profiles
- Analyst Views
- Future Outlook of the Market